The DOI matches its OpenAlex record; 7 of the 7 references it cites were found in a registry or an index.
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Open accessAbstract
Recent evidence has defined an important role for PPARalpha in the transcriptional control of cardiac energy metabolism. To investigate the role of PPARalpha in the genesis of the metabolic and functional derangements of diabetic cardiomyopathy, mice with cardiac-restricted overexpression of PPARalpha (MHC-PPAR) were produced and characterized. The expression of PPARalpha target genes involved in cardiac fatty acid uptake and oxidation pathways was increased in MHC-PPAR mice. Surprisingly, the expression of genes involved in glucose transport and utilization was reciprocally repressed in MHC-PPAR hearts. Consistent with the gene expression profile, myocardial fatty acid oxidation rates were increased and glucose uptake and oxidation decreased in MHC-PPAR mice, a metabolic phenotype strikingly similar to that of the diabetic heart. MHC-PPAR hearts exhibited signatures of diabetic cardiomyopathy including ventricular hypertrophy, activation of gene markers of pathologic hypertrophic growth, and transgene expression-dependent alteration in systolic ventricular dysfunction. These results demonstrate that (a) PPARalpha is a critical regulator of myocardial fatty acid uptake and utilization, (b) activation of cardiac PPARalpha regulatory pathways results in a reciprocal repression of glucose uptake and utilization pathways, and (c) derangements in myocardial energy metabolism typical of the diabetic heart can become maladaptive, leading to cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
What if Minkowski Had Been Ageusic? An Alternative Angle on Diabetes
McGarry, J. D. (1992) · Science · doi:10.1126/science.1439783 · Cited by 657
Regulation of energy substrate metabolism in the diabetic heart
Stanley, W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00047-3 · Cited by 480
Djouadi, F., Weinheimer, C. J., Saffitz, J. E., Pitchford, C., Bastin, J., Gonzalez, F. J., & Kelly, D. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3949 · Cited by 410
Self-citation
Research works printed but not linked: 33
- Kannel, 1974, Am J Cardiol, 34, 29, 10.1016/0002-9149(74)90089-7 · DOI · Paper page
- Rubler, 1972, Am J Cardiol, 30, 595, 10.1016/0002-9149(72)90595-4 · DOI · Paper page
- Rodrigues, 1995, J Mol Cell Cardiol, 27, 169, 10.1016/S0022-2828(08)80016-8 · DOI · Paper page
- Neely, 1972, Prog Cardiovasc Dis, 15, 289, 10.1016/0033-0620(72)90029-1 · DOI · Paper page
- Lopaschuk, 1989, Circ Res, 65, 378, 10.1161/01.RES.65.2.378 · DOI
- Murthy, 1977, Diabetes, 26, 222, 10.2337/diabetes.26.3.222 · doi:10.2337/diabetes.26.3.222
- Paulson, 1982, Am J Physiol, 242, 1084
- Chiu, 2001, J Clin Invest, 107, 813, 10.1172/JCI10947 · DOI · Paper page
- Barger, 2000, Trends Cardiovasc Med, 10, 238, 10.1016/S1050-1738(00)00077-3 · DOI · Paper page
- Lee, 1995, Mol Cell Biol, 15, 3012, 10.1128/MCB.15.6.3012 · DOI · Paper page
- Aoyama, 1998, J Biol Chem, 273, 5678, 10.1074/jbc.273.10.5678 · DOI · Paper page
- Leone, 1999, Proc Natl Acad Sci USA, 96, 7473, 10.1073/pnas.96.13.7473 · DOI · Paper page
- Kersten, 1999, J Clin Invest, 103, 1489, 10.1172/JCI6223 · DOI · Paper page
- Asayama, 1999, Mol Cell Biochem, 194, 227, 10.1023/A:1006930513476 · DOI
- Memon, 2000, Endocrinology, 141, 4021, 10.1210/en.141.11.4021 · DOI
- Kroetz, 1998, J Biol Chem, 273, 31581, 10.1074/jbc.273.47.31581 · DOI · Paper page
- Belke, 1999, Am J Physiol, 277, R1210, 10.1152/ajpcell.1999.277.6.C1210 · DOI · Paper page
- Cresci, 1996, Am J Physiol, 270, C1413, 10.1152/ajpcell.1996.270.5.C1413 · DOI
- Esser, 1996, J Biol Chem, 271, 6972, 10.1074/jbc.271.12.6972 · DOI
- Han, 2001, Anal Biochem, 295, 88, 10.1006/abio.2001.5178 · DOI · Paper page
- Young, 2001, FASEB J, 15, 833, 10.1096/fj.00-0351com · DOI · Paper page
- Depre, 2000, J Mol Cell Cardiol, 32, 985, 10.1006/jmcc.2000.1139 · DOI · Paper page
- Belke, 2000, Am J Physiol, 279, E1104
- Wu, 1998, Biochem J, 329, 197, 10.1042/bj3290197 · DOI · Paper page
- Ahmed, 1975, Am Heart J, 89, 153, 10.1016/0002-8703(75)90039-3 · DOI · Paper page
- Dillmann, 1988, Diabetes Metab Rev, 4, 789, 10.1002/dmr.5610040807 · doi:10.1002/dmr.5610040807
- Taegtmeyer, 1997, Am J Cardiol, 80, 3A, 10.1016/S0002-9149(97)00452-9 · DOI
- Lewandowski, 1995, Circulation, 91, 2071, 10.1161/01.CIR.91.7.2071 · DOI
- McVeigh, 1990, Am J Physiol, 259, H1079
- Tian, 2001, Circulation, 103, 2961, 10.1161/01.CIR.103.24.2961 · DOI · Paper page
- Frayne, 1993, Curr Opin Lipidol, 4, 197, 10.1097/00041433-199306000-00004 · DOI · Paper page
- Kim, 2001, Proc Natl Acad Sci USA, 98, 7522, 10.1073/pnas.121164498 · DOI · Paper page
- Wu, 1999, Diabetes, 48, 1593, 10.2337/diabetes.48.8.1593 · DOI · Paper page
Cited by
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
“PGC-1α mRNA levels are elevated in the myocardium of streptozotocin-treated and db/db mice (Finck et al., 2002), suggesting that this coactivator may play a role in the development of diabetic cardiomyopathy.”
BackgroundDiabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543
Sorting out the roles of PPAR in energy metabolism and vascular homeostasis
Lefebvre, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27989 · Cited by 962
Han, X., & Gross, R. W. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300004-jlr200 · Cited by 914
Self-citationMolecular mechanisms of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3171-6 · Cited by 903
Metadata
- Authors
- Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., & Kelly, D. P.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-01-01
- Volume
- 109
- Issue
- 1
- Pages
- 121-130
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2162919259
- Cited by
- 879
- References
- 7
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. https://app.cochat.ai/papers/10.1172/jci14080
- The paper
- Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., & Kelly, D. P. (2002). The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. Journal of Clinical Investigation. https://doi.org/10.1172/jci14080
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.